Letizia Procaccio

Variant allele frequency in baseline circulating tumour DNA to measure tumour burden and to stratify outcomes in patients with RAS wild-type metastatic colorectal cancer: a translational objective of the Valentino study

Paolo Manca, Salvatore Corallo, Sara Lonardi et al. · British Journal of Cancer · 2021 · 36 citations · Full text

Medicine, Genetics, Oncology +17

High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With Regorafenib

Alessio Amatu, Marta Schirripa, Federica Tosi et al. · Frontiers in Oncology · 2019 · 34 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

Somaieh Hedayat, Luciano Cascione, David Cunningham et al. · Clinical Cancer Research · 2024 · 33 citations

Medicine, Molecular Medicine, Oncology +17

The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer

Paolo Manca, Salvatore Corallo, Adele Busico et al. · Clinical Cancer Research · 2021 · 24 citations · Full text

Medicine, Molecular Genetics, Oncology +17

The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma

Letizia Procaccio, Valeria Merz, Morena Fasano et al. · Cancer Medicine · 2023 · 18 citations · Full text

Medicine, Oncology, Pharmacology +17